Maisha Meds, a Kenyan health tech company, has successfully raised $5 million in funding to support the expansion of its mobile software platform. The investment comes as a significant boost to the company’s mission of improving access to affordable and quality healthcare in Kenya.
Maisha Meds offers a mobile-based platform that focuses on the management and distribution of essential medicines in Kenya. The platform connects healthcare providers, patients, and pharmacies, allowing for the efficient tracking of medical inventory, patient prescription data, and medication adherence. This innovative solution has been instrumental in addressing critical healthcare challenges in Kenya.
The $5 million funding from the United States Agency for International Development (USAID) Development Innovation Ventures (DIV) disbursed over three years, will support Maisha Meds’ expansion efforts to reach people in need of affordable, high-quality malaria care across Africa through private drug shops, pharmacies, and clinics. Maisha Meds plans to utilize the funding to enhance its mobile platform, expand its network of partner pharmacies and healthcare facilities, and reach more underserved communities across Kenya.
The mobile platform developed by Maisha Meds not only benefits healthcare providers but also empowers patients by providing them with access to important information about their medications and treatment regimens. This not only improves patient adherence but also enhances the overall healthcare experience.
This investment is a testament to the growing interest in healthcare technology and digital health solutions in Kenya and across Africa. As Maisha Meds continues to make strides in improving healthcare access, it is poised to become a key player in the ongoing transformation of the healthcare sector in Kenya and beyond.
